List of Tables and Boxes | p. x |
Acknowledgements | p. xii |
Introduction | |
Introduction: Medicines in Time and Space | p. 3 |
Introduction | p. 3 |
Historical Use of Medicines | p. 5 |
The Role of Professionals | p. 9 |
The International Context | p. 12 |
Theoretical Approach | p. 14 |
Scope and Structure of the Book | p. 20 |
Lifeworld Perspectives | |
Self-care and Complementary Therapies | p. 25 |
Introduction | p. 25 |
The Popular Sector | p. 26 |
The Informal Sector | p. 30 |
Conclusion | p. 42 |
Medicines in the Lifeworld | p. 45 |
Introduction | p. 45 |
Lifeworld Metaphors and Meanings | p. 45 |
Lay Perspectives on Medicines | p. 49 |
Lay Testing of Medicines | p. 51 |
Ways People Take Medicines | p. 54 |
Managing Everyday Life | p. 57 |
The Problem of 'Non-compliance' | p. 59 |
Construction of Shared Knowledge | p. 61 |
Conclusion | p. 62 |
System Perspectives | |
The Development and Licensing of Medicines | p. 67 |
Introduction | p. 67 |
The Development of Drug Regulation | p. 69 |
Development of Medicines | p. 72 |
Testing and Licensing of Medicines | p. 75 |
Post-licensing | p. 79 |
Involvement of Patients and the General Public | p. 81 |
Conclusion | p. 85 |
Information about Medicines | p. 87 |
Introduction | p. 87 |
Information for Professionals | p. 87 |
Information for Patients | p. 90 |
Conclusion | p. 104 |
Prescribing | p. 106 |
Introduction | p. 106 |
What is Good Prescribing? | p. 107 |
Prescribing Decisions | p. 111 |
System Imperatives - the Pharmaceutical Industry | p. 116 |
System Imperatives - Attempts to Rationalize Prescribing | p. 119 |
Conclusion | p. 123 |
The Interface between System and Lifeworld | |
Patient-Professional Communication | p. 129 |
Introduction | p. 129 |
Nurse Prescribing | p. 131 |
Patients' Influence on Prescribing | p. 134 |
System and Lifeworld in Health Care Consultations | p. 138 |
Strategic or Communicative Action? | p. 146 |
Conclusion | p. 149 |
Collective Action | p. 152 |
Introduction | p. 152 |
Types of Groups | p. 152 |
Prioritizing the Lifeworld | p. 156 |
Relationships with Other Stakeholders | p. 164 |
Conclusion | p. 171 |
Conclusion | |
Balance between System and Lifeworld | p. 177 |
Introduction | p. 177 |
Lifeworld and System | p. 178 |
Patient and Public Involvement | p. 181 |
Lay Involvement in Different Stages of the Life Cycle of Medicines | p. 182 |
Conclusion | p. 190 |
References | p. 191 |
Index | p. 203 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.